Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Hagmeyer

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Respiratory Research|March 17, 2019
The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registryMichael Kreuter, Jeff Swigris, David Pittrow, et al.
Respiratory Research|July 16, 2017
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registryMichael Kreuter, Jeff Swigris, David Pittrow, et al.
Pneumologie (Stuttgart, Germany)|March 24, 2026
[Safety of diagnostic flexible bronchoscopy in adults S2k-Guideline of the German Respiratory Society]Ralf-Harto Hübner, Jürgen Hetzel, Barbara Baysal, et al.
The European Respiratory Journal|December 7, 2016
Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleepWinfried Randerath, Johan Verbraecken, Stefan Andreas, et al.
ERJ Open Research|January 21, 2026
Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysisJürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Respiration; International Review of Thoracic Diseases|January 10, 2018
Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the ProcedureJürgen Hetzel, Fabien Maldonado, Claudia Ravaglia, et al.
American Journal of Respiratory and Critical Care Medicine|July 30, 2020
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial PneumoniaLuca Richeldi, Mary Beth Scholand, David A Lynch, et al.
The Lancet. Respiratory Medicine|April 6, 2019
Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation studyGanesh Raghu, Kevin R Flaherty, David J Lederer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2019
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic PathwaysMatthias Scheffler, Michaela A Ihle, Rebecca Hein, et al.
ERJ Open Research|June 10, 2025
Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registryJürgen Behr, Michael Kreuter, Andreas U Guenther, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Respiratory Research|March 17, 2019
The clinical course of idiopathic pulmonary fibrosis and its association to quality of life over time: longitudinal data from the INSIGHTS-IPF registryMichael Kreuter, Jeff Swigris, David Pittrow, et al.
Respiratory Research|July 16, 2017
Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registryMichael Kreuter, Jeff Swigris, David Pittrow, et al.
Pneumologie (Stuttgart, Germany)|March 24, 2026
[Safety of diagnostic flexible bronchoscopy in adults S2k-Guideline of the German Respiratory Society]Ralf-Harto Hübner, Jürgen Hetzel, Barbara Baysal, et al.
The European Respiratory Journal|December 7, 2016
Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleepWinfried Randerath, Johan Verbraecken, Stefan Andreas, et al.
ERJ Open Research|January 21, 2026
Risk stratification as a guide to goal-oriented management of patients with fibrotic interstitial lung disease: a registry-based analysisJürgen Behr, Antje Prasse, Hubert Wirtz, et al.
Respiration; International Review of Thoracic Diseases|January 10, 2018
Transbronchial Cryobiopsies for the Diagnosis of Diffuse Parenchymal Lung Diseases: Expert Statement from the Cryobiopsy Working Group on Safety and Utility and a Call for Standardization of the ProcedureJürgen Hetzel, Fabien Maldonado, Claudia Ravaglia, et al.
American Journal of Respiratory and Critical Care Medicine|July 30, 2020
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial PneumoniaLuca Richeldi, Mary Beth Scholand, David A Lynch, et al.
The Lancet. Respiratory Medicine|April 6, 2019
Use of a molecular classifier to identify usual interstitial pneumonia in conventional transbronchial lung biopsy samples: a prospective validation studyGanesh Raghu, Kevin R Flaherty, David J Lederer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 4, 2019
K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic PathwaysMatthias Scheffler, Michaela A Ihle, Rebecca Hein, et al.
ERJ Open Research|June 10, 2025
Real-life characteristics and management of patients with fibrosing interstitial lung disease: INSIGHTS-ILD registryJürgen Behr, Michael Kreuter, Andreas U Guenther, et al.
Pageof 7